CPODX
Price
$59.90
Change
+$0.41 (+0.69%)
Updated
Sep 5 closing price
Net Assets
1.55B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

CPODX vs RGEBX

Header iconCPODX vs RGEBX Comparison
Open Charts CPODX vs RGEBXBanner chart's image
Morgan Stanley Insight I
Price$59.90
Change+$0.41 (+0.69%)
VolumeN/A
Net Assets1.55B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
CPODX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CPODX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPODX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. CPODX (1.55B). CPODX pays higher dividends than RGEBX: CPODX (0.52) vs RGEBX (0.00). CPODX was incepted earlier than RGEBX: CPODX (28 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than CPODX (0.90). CPODX is a more actively managed with annual turnover of: 44.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than CPODX: RGEBX (250) vs CPODX (1000000). CPODX annual gain was more profitable for investors over the last year : 76.89 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. CPODX (-24.49).
CPODXRGEBXCPODX / RGEBX
Total Expense Ratio0.901.0983%
Annual Report Gross Expense Ratio0.901.0983%
Fund Existence28 years11 years-
Gain YTD25.18315.398164%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B332B0%
Annual Yield % from dividends0.520.00-
Returns for 1 year76.8917.59437%
Returns for 3 years69.7657.61121%
Returns for 5 years-24.4938.71-63%
Returns for 10 years70.2291.4477%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In